Stryker (SYK) Income from Continuing Operations (2009 - 2026)

Stryker's (SYK) quarterly Income from Continuing Operations came in at 745000000.0 in Q1 2026, up 13.91% year-on-year from 654000000.0 in Q1 2025, and down 12.25% on a QoQ basis from 849000000.0 in Q4 2025.

Stryker (SYK) Income from Continuing Operations (2009 - 2026) Analysis & Trends

Stryker (SYK) has 18 years of Income from Continuing Operations data on file, last reported at 745000000.0 in Q1 2026.

  • On a quarterly basis, Income from Continuing Operations rose 13.91% year-over-year to 745000000.0 in Q1 2026; TTM through Mar 2026 was 3337000000.0, a 16.72% increase from a year earlier, with the FY2025 full-year figure at 3246000000.0, up 8.45% from the prior year.
  • Income from Continuing Operations for Q1 2026 stood at 745000000.0, down from 849000000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for SYK reached as high as 1143000000.0 in Q4 2023 and fell as low as 323000000.0 in Q1 2022.
  • Historically, Income from Continuing Operations has averaged 735705882.35 across 5 years, with a median of 745000000.0 in 2026.
  • Across the five-year window, Income from Continuing Operations jumped 103.02% in 2023 and slumped 52.23% in 2024, its largest moves.
  • Year by year, Income from Continuing Operations stood at 563000000.0 in 2022, then soared by 103.02% to 1143000000.0 in 2023, then slumped by 52.23% to 546000000.0 in 2024, then surged by 55.49% to 849000000.0 in 2025, then slipped by 12.25% to 745000000.0 in 2026.
  • Per Business Quant data, the three most recent Income from Continuing Operations figures were 745000000.0 in Q1 2026, 849000000.0 in Q4 2025, and 859000000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 1.08 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 745.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 380.70 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 199.50 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 273.95 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 411.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn 220.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 745.00 Mn
Dec 31, 2025 849.00 Mn
Sep 30, 2025 859.00 Mn
Jun 30, 2025 884.00 Mn
Mar 31, 2025 654.00 Mn
Dec 31, 2024 546.00 Mn
Sep 30, 2024 834.00 Mn
Jun 30, 2024 825.00 Mn
Mar 31, 2024 788.00 Mn
Dec 31, 2023 1.14 Bn
Sep 30, 2023 692.00 Mn
Jun 30, 2023 738.00 Mn
Mar 31, 2023 592.00 Mn
Dec 31, 2022 563.00 Mn
Sep 30, 2022 816.00 Mn
Jun 30, 2022 656.00 Mn
Mar 31, 2022 323.00 Mn
Dec 31, 2021 662.00 Mn
Sep 30, 2021 438.00 Mn
Jun 30, 2021 592.00 Mn